Anti-inflammatory and anti-oxidative effects of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on β-amyloid-induced microglial activation
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
We aimed to assess the anti-inflammatory and antioxidative properties of KHG26792, a novel azetidine derivative, in amyloid β (Aβ)-treated primary microglial cells. KHG26792 attenuated the Aβ-induced production of inflammatory mediators such as IL-6, IL-1β, TNF-α, and nitric oxide. The levels of protein oxidation, lipid peroxidation, ROS, and NADHP oxidase enhanced by Aβ were also downregulated by KHG26792 treatment. The effects of KHG26792 against the Aβ-induced increases in inflammatory cytokine levels and oxidative stress were achieved by increasing the phosphorylation of Akt/ GSK-3β signaling and by decreasing the Aβ-induced translocation of NF-κB. Our results provide novel insights into the use of KHG26792 as a potential agent against Aβ toxicity, including its role in the reduction of inflammation and oxidative stress. Nevertheless, further investigations of cellular signaling are required to clarify the in vivo effects of KHG26792 against Aβ-induced toxicity.
Abstract
We aimed to assess the anti-inflammatory and antioxidative properties of KHG26792, a novel azetidine derivative, in amyloid β (Aβ)-treated primary microglial cells. KHG26792 attenuated the Aβ-induced production of inflammatory mediators such as IL-6, IL-1β, TNF-α, and nitric oxide. The levels of protein oxidation, lipid peroxidation, ROS, and NADHP oxidase enhanced by Aβ were also downregulated by KHG26792 treatment. The effects of KHG26792 against the Aβ-induced increases in inflammatory cytokine levels and oxidative stress were achieved by increasing the phosphorylation of Akt/ GSK-3β signaling and by decreasing the Aβ-induced translocation of NF-κB. Our results provide novel insights into the use of KHG26792 as a potential agent against Aβ toxicity, including its role in the reduction of inflammation and oxidative stress. Nevertheless, further investigations of cellular signaling are required to clarify the in vivo effects of KHG26792 against Aβ-induced toxicity.
참고문헌 (32)
- Cerpa W, "Structure–function implications in Alzheimer’s disease: effect of Abeta oligomers at central synapses", Curr Alzheimer Res, 5, pp.233~243 (2008)
- Li J, "Oligomeric A-induced microglial activation is possibly mediated by NADPH oxidase", Neurochem Res, 38, pp.443~452 (2013)
- Guo Y, "The suppressive effects of gx-50 on A-induced chemotactic migration of microglia", Int Immunopharmacol, 19, pp.283~289 (2014)
- Mosher KI, "Microglial dysfunction in brain aging and Alzheimer's disease", Biochem Pharmacol, 88, pp.594~604 (2014)
- Krementsov DN, "The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models", Mol Cell Biol, 33, pp.3728~3734 (2013)
- Lowe JT, "Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries", J Org Chem, 77, pp.7187~7211 (2012)
- Dalla Y, "Potential of ezetimibe in memory deficits associated with dementia of Alzheimer’s type in mice", Indian J Pharmacol, 41, pp.262~267 (2009)
- Han M, "Exploration of 3-aminoazetidines as triple reuptake inhibitors by bioisosteric modification of 3-aoxyazetidine", ACS Med Chem Lett, 5, pp.999~1004 (2014)
- Yun J, "Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors", Bioorg Med Chem Lett, 24, pp.3234~3237 (2014)
- Kim EA, "The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia", Neurotoxicology, 51, pp.198~206 (2015)
- 김지애, "Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells", BMB Reports, 49(12), pp.687~692 (2016), 생화학분자생물학회
- Ebert S, "Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination", J Neuroimmunol, 159, pp.87~96 (2005)
- Bach JP, "The role of CNI-1493 in the function of primary microglia with respect to amyloid-beta", J Alzheimers Dis, 26, pp.69~80 (2011)
- Shahani N, "Nitric oxide signaling and nitrosative stress in neurons: role for S-nitrosylation", Antioxid Redox Signal, 14, pp.1493~1504 (2011)
- Tayler H, "Oxidative balance in Alzheimer's disease: Relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-", J Alzheimers Dis, 22, pp.1363~1373 (2010)
- Butterfield DA, "Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide associated free radical oxidative stress", Free Radic Biol Med, 32, pp.1050~1060 (2002)
- Sultana R, "Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity", J Neurochem, 92, pp.749~758 (2005)
- Qureshi GA, "Neurotoxicity, oxidative stress and cerebrovascular disorders", Neurotoxicology, 25, pp.121~138 (2004)
- Chen JX, "Role of mitochondrial amyloid-beta in Alzheimer’s disease", J Alzheimers Dis, 20, pp.S569~S578 (2010)
- Part K, "Amyloid 25-35 induced ROS-burst through NADPH oxidase is sensitive to iron chelation in microglial Bv2 cells", Brain Res, 1629, pp.282~290 (2015)
- Yao Y, "Resveratrol inhibits oligomeric A-induced microglial activation via NADPH oxidase", Mol Med Rep, 12, pp.6131~6139 (2015)
- Hernandez F, "GSK3 and tau: two convergence points in Alzheimer’s disease", J Alzheimers Dis, 33, pp.S141~S144 (2013)
- Zou Y, "Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3", Nrf2 signaling pathway, 2013, pp.47, 55~63
- Dobarro M, "Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer’s transgenic mice", Int J Neuropsychopharmacol, 16, pp.2245~2257 (2013)
- Terai K, "Enhancement of immunoreactivity for NF-kappaB in the hippocampal formation and cerebral cortex of Alzheimer's disease", Brain Res, 735, pp.159~168 (1996)
- Zhang J, "Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus", Behav Brain Res, 244, pp.70~81 (2013)
- Zhu X, "Activation of MKK6, an upstream activator of p38, in Alzheimer’s disease", J Neurochem, 79, pp.311~318 (2001)
- Han Y, "Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors", J Med Chem, 55, pp.8188~8192 (2012)
- 김승재, "Corosolic acid ameliorates acute inflammation through inhibition of IRAK-1 phosphorylation in macrophages", BMB Reports, 49(5), pp.276~281 (2016), 생화학분자생물학회
- Reznick AZ, "Oxidative damage to proteins: spectrophotometric method for carbonyl assay", Methods Enzymol, 233, pp.357~363 (1994)
- Lauderback CM, "The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer’s disease brain: the role of amyloid beta (1–42)", J Neurochem, 78, pp.413~416 (2001)
- Li MH, "Protective effects of oligomers of grape seed polyphenols against beta-amyloid induced oxidative cell death", Ann NY Acad Sci, 1030, pp.317~329 (2004)